These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 27717650

  • 1. The distribution and drug susceptibilities of clinical Candida species in TSARY 2014.
    Zhou ZL, Lin CC, Chu WL, Yang YL, Lo HJ, TSARY Hospitals.
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):399-404. PubMed ID: 27717650
    [Abstract] [Full Text] [Related]

  • 2. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M, Fan X, Chen SC, Wang H, Sun ZY, Liao K, Chen SL, Yan Y, Kang M, Hu ZD, Chu YZ, Hu TS, Ni YX, Zou GL, Kong F, Xu YC.
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [Abstract] [Full Text] [Related]

  • 3. Species distribution and drug susceptibilities of Candida isolates in TSARY 2010.
    Yang YL, Chen HT, Lin CC, Chu WL, Lo HJ, TSARY Hospitals.
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):182-6. PubMed ID: 23574935
    [Abstract] [Full Text] [Related]

  • 4. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC.
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [Abstract] [Full Text] [Related]

  • 5. The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan.
    Yang YL, Li SY, Cheng HH, Lo HJ, TSARY Hospitals.
    BMC Infect Dis; 2005 Nov 03; 5():99. PubMed ID: 16266438
    [Abstract] [Full Text] [Related]

  • 6. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR, Lau YJ, Chuang YC, Wan JH, Huang WK, Shyr JM, Yan JJ, Yu KW, Wu JJ, Ko WC, Yang YC, Liu YC, Teng LJ, Liu CY, Luh KT.
    Antimicrob Agents Chemother; 2005 Feb 03; 49(2):512-7. PubMed ID: 15673726
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.
    Yang YL, Li SY, Cheng HH, Lo HJ, TSARY Hospitals.
    Diagn Microbiol Infect Dis; 2005 Mar 03; 51(3):179-83. PubMed ID: 15766603
    [Abstract] [Full Text] [Related]

  • 9. Mixed yeast infections in Taiwan.
    Yang YL, Chu WL, Lin CC, Zhou ZL, Chen PN, Lo HJ, TSARY Hospitals.
    Med Mycol; 2018 Aug 01; 56(6):770-773. PubMed ID: 29087478
    [Abstract] [Full Text] [Related]

  • 10. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
    Panizo MM, Reviákina V, Dolande M, Selgrad S.
    Med Mycol; 2009 Mar 01; 47(2):137-43. PubMed ID: 18651308
    [Abstract] [Full Text] [Related]

  • 11. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis.
    Yang YL, Ho YA, Cheng HH, Ho M, Lo HJ.
    Infect Control Hosp Epidemiol; 2004 Jan 01; 25(1):60-4. PubMed ID: 14756222
    [Abstract] [Full Text] [Related]

  • 12. The distribution of species and susceptibility of amphotericin B and fluconazole of yeast pathogens isolated from sterile sites in Taiwan.
    Yang YL, Cheng MF, Wang CW, Wang AH, Cheng WT, Lo HJ, Hospitals T.
    Med Mycol; 2010 Mar 01; 48(2):328-34. PubMed ID: 20141372
    [Abstract] [Full Text] [Related]

  • 13. Five-Year National Surveillance of Invasive Candidiasis: Species Distribution and Azole Susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study.
    Xiao M, Sun ZY, Kang M, Guo DW, Liao K, Chen SC, Kong F, Fan X, Cheng JW, Hou X, Zhou ML, Li Y, Yu SY, Huang JJ, Wang H, Xu YC, China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study Group.
    J Clin Microbiol; 2018 Jul 01; 56(7):. PubMed ID: 29743305
    [Abstract] [Full Text] [Related]

  • 14. Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study.
    Mokaddas EM, Al-Sweih NA, Khan ZU.
    J Med Microbiol; 2007 Feb 01; 56(Pt 2):255-259. PubMed ID: 17244809
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of voriconazole against Candida species isolated in Taiwan.
    Yang YL, Cheng HH, Lo HJ.
    Int J Antimicrob Agents; 2004 Sep 01; 24(3):294-6. PubMed ID: 15325436
    [Abstract] [Full Text] [Related]

  • 16. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
    Ozhak-Baysan B, Ogunc D, Colak D, Ongut G, Donmez L, Vural T, Gunseren F.
    Med Mycol; 2012 Jul 01; 50(5):529-32. PubMed ID: 21988703
    [Abstract] [Full Text] [Related]

  • 17. Candida infection in the intensive care unit: A study of antifungal susceptibility pattern of Candida species in Milad hospital, Tehran, Iran.
    Alimehr S, Shekari Ebrahim Abad H, Fallah F, Rahbar M, Mohammadzadeh M, Vossoghian S, Rafeei Tabatabaee S, Roudbary M, Zaini F.
    J Mycol Med; 2015 Dec 01; 25(4):e113-7. PubMed ID: 26563641
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Species distribution and fluconazole susceptibility of Candida clinical isolates in a medical center in 2002.
    Wang JL, Chang SC, Hsueh PR, Chen YC.
    J Microbiol Immunol Infect; 2004 Aug 01; 37(4):236-41. PubMed ID: 15340652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.